Nomi Health’s Post

#HealthTechSuperconnector - a great session put on by Coulter Partners during #LondonTechWeek. Brilliant to meet so many new people and reconnect with familiar faces and old colleagues. A couple of take aways both from this session and others during the week: 1) Deal flow is waking up. Lots of comments and energy around invigorated deal flow, but also a realisation that we need to look at talent differently, ops and technology differently. New and orthogonal perspectives are needed to ensure value propositions are fresh and highly differentiated. 2) The Pharma to Pro-sumer to Consumer continuum is blurring more and more. The need for LifeSciences-lead companies to position and speak in a far more simple and consumer-lead (read ‘human’) way is really apparent. Likewise, Consumer companies are looking to more regulated and ‘traditional’ markets to unlock new growth. Believability at both ends of the spectrum is potentially lacking and needs to be addressed in order to drive impact to the P&L. 3) Focus and Conviction: The world is moving quickly, and that can lead to either a hive of non-strategic activity or just standing still. Both are bad. Investors, Founders and corp side innovators are charged with delivering more than ever for impactful outcomes, but in this current environment is less about creating the next Unicorn and more about paced progress against the investment ask. I really enjoyed it. Thanks to the #CoulterPartners team and to Ian Coyne for the invite. Until next time! With... Malcolm Fogarty Esther Reynal de St Michel Richardot Chantal Noble Haldorsen Chantal Cox Kelly McCabe Maya Ward Konrad Dobschuetz Joel Schoppig Cédric Degryse Morgan Fitzsimons Neil Newman Katia Lang Jaspreet K Grewal, MBA Alice Adamczyk Tony Kypreos

Heading to HLTH USA 2024? Join me on 10/22 for a panel titled "Consumer Wellness Means Business," where we'll discuss the early-stage investment climate, consumer priorities and trends that will lead us into 2025 and beyond. I look forward to sharing this discussion with Cathy Friedman of GV (Google Ventures), Amanda Eilian of Able Partners & Scott Barclay of Insight Partners. See you there! #HLTHUSA #HLTH #healthcareinnovation

In 2021, we all saw Medtech and digital health valuations exploding and plenty of massive rounds of funding. We also saw the market correct, seeing an estimated 25% decrease in valuations across the industry. As a founder: - How do you protect yourself from these painful corrections? - How do you raise capital in the wake of those corrections? - How does this affect who you choose to pitch and partner with? You need to ask yourself these tough questions to ensure that you’re generating real value for stakeholders throughout the investment and exit processes. The market is constantly shifting, but these lessons will always serve you well. This is a great panel to rewatch now that you have some hindsight and have seen how things have played out in recent years. Watch the full panel, Creating Stakeholder Value from Investment to Exit, on our website.

📈 The life sciences and health care industry is undergoing a series of significant sector-level transformations that are fundamentally changing the basis of competition and driving the continued reassembly of the industry. “To win amidst these dynamics, private equity firms and their portfolio companies will need to embrace a platform-centric business model that can create exponential value for its ecosystem.” 📊 Read more 👉 https://lnkd.in/es_uTxK5

Meet the Digital Health 50 — our ranking of the most promising digital health startups in the world. How did these companies earn a spot? We mined CB Insights data to evaluate company performance across a number of areas. We looked at: ▪️ R&D activity ▪️ Mosaic scores ▪️ Business relationships ▪️ Software buyer transcripts ▪️ Investor profiles ▪️ And more The winning cohort is a diverse bunch, working on everything from making healthcare AI safer to boosting the accessibility of clinical trials. Learn more about our winners and the areas they’re transforming in the full report: https://cbi.team/4cM854K

News from JP Morgan Conference🇺🇸 An inspiring session dedicated to MedTech CEO-Only Forum thanks to the experience of the experts panel and the interactive contributions of the attendees. During more than two hours, we could share learnings on CEO missions, management challenges, talents hiring difficulties, distribution opportunities, partners selection, tips on funding raising… and at the end of the day, reinforce our feeling of the chance we have to deliver positive impact on people health.

Sometimes holidays make you realise how small and interconnected our planet is… Great insights shared by my PE-focused colleagues in Chicago, with valuable resonance in EMEA markets. Their emphasis on the themes underpinning investing in Healthcare assets - highlights global trends that transcend geos. Thanks Ropes & Gray LLP Chicago #PrivateEquity #HealthcareInvesting #GlobalTrends

Impact strategies drive DISTINCTIVE value creation, when done right – and here are 13 case studies to prove it.    Well done to the Tideline and Impact Capital Managers teams for collating these diverse illustrations, showing how impact investors can enhance both financial and impact performance in this report, “New Frontiers in Value Creation”.   The LeapFrog Investments’ healthcare team is featured for their work with Redcliffe Labs. In just a short time working together, Redcliffe has broadened its product offering, improved its reach into underserved areas of India and enhanced governance, including embedding impact through the business. This drives greater scale, quality and impact for Redcliffe’s essential diagnostic tests.    Read it here: https://lnkd.in/gFpgBJfe   Biju Mohandas Dr. Vikram Popli Eshani Shah Niyati Dangi #impactinvesting #valuecreation 

Leading life sciences companies are transforming healthcare, but innovation often brings complex challenges. FTI Consulting's deep industry expertise is here to help you overcome obstacles—from asset forecasting and valuation to building commercial capabilities—and create lasting impact across the healthcare ecosystem. Explore how: https://lnkd.in/g8uzhBbE

If you are eligible and interested, or if you know anyone interested - I’d love to help you get signed up! More info in the attached post. #angelinvestors #mn #greatermsp #equity #groovegapital #twinignition